EGM
DFTX

Engineers Gate Manager’s Definium Therapeutics DFTX Stock Holding History

Engineers Gate Manager’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$563K Buy
+29,767
New +$505K 0.01% 1349
2023
Q1 		– Sell
-10,076
Closed -$22.2K – 1866
2022
Q4 		$22.2K Buy
+10,076
New +$28K ﹤0.01% 1598
2021
Q3 		– Sell
-1,143
Closed -$59K – 1842
2021
Q2 		$59K Buy
+1,143
New +$60K ﹤0.01% 1540

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Engineers Gate Manager's DFTX Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 29,767 shares worth $563K. The stake represents 0.01% of the portfolio and ranks #1349 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in DFTX as recently as Q4 2022.

Engineers Gate Manager first reported a position in DFTX in Q2 2021 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Engineers Gate Manager held 29,767 shares of Definium Therapeutics worth $563K as of Q1 2026.
  • Definium Therapeutics was a new Engineers Gate Manager position in Q1 2026.
  • Definium Therapeutics made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1349 holding.
  • Engineers Gate Manager first reported a position in Definium Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.